| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.71 | 0.009 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.36 | 0.2 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.22 | 9e-11 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.21 | 4e-11 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.21 | 0.5 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.2 | 2e-09 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.19 | 1e-09 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0007 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.18 | 5e-08 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.18 | 2e-08 |